Keystone Symposia announces virtual ePanel on drug discovery

Keystone Symposia is pleased to announce that it will host a free ePanel discussion on April 26, 2018 at 2:30 PM EST/6:30 PM BST.

Go to the profile of RxNet
Apr 23, 2018
0
0

Keystone Symposia on Molecular and Cellular Biology is holding a free virtual webcast on Drug Discovery: Current Trends in Medicinal Chemistry on April 26 2018 at 2:30 PM EST/6:30 PM BST. Dr Walter Moos (ShangPharma Innovation, CA, USA) will lead a roundtable discussion with four experts from biopharma on the challenges, pitfalls and opportunities in drug discovery today.

Topics of discussion include:

  • How well do lead-finding technologies work compared to classical medicinal chemistry techniques?
  • What potential is there for products such as peptides, proteins, antibodies and RNA-based therapies in light of the fact that nearly all the most prescribed therapeutics remain small molecule drugs?
  • What is the optimal balance of in-house R&D vs outsourced work (e.g. CROs) throughout the drug discovery process?
  • How can industry build more symbiotic partnerships with academia?

Panelists will answer audience questions live at the end of the panel discussion; you can submit a question when registering, via the chat room or on Twitter using the hashtag #VKSdrugdisc.

Registration is free at: bit.ly/VKSdrugdisc 
Watch a preview at: bit.ly/VKSdrugdiscpreview

Moderator:

  • Walter H. Moos, ShangPharma Innovation and University of California, San Francisco

Panelists: 

  • Gina Xiaojing Wang, Genentech, Inc. (CA, USA)
  • Dmitry O. Koltun, Gilead Sciences, Inc. (CA, USA)
  • Chudi Ndubaku, Aduro Biotech, Inc. (CA, USA) 
  • Eric B. Harstad, Theravance Biopharma (CA, USA; joining for the Q&A)
Go to the profile of RxNet

RxNet

A network for the drug discovery and development community, Future Science Group

Your source for the latest news and views from the fields of drug discovery and medicinal chemistry.

No comments yet.